I generally don't make a practice of reporting on new drugs that are still in the clinical trial phases of development because it takes so many years to bring a new drug to market and you never know what might happen to them along the way.  But there are two new drugs in the final phase of clinical trials that I find particularly interesting and promising.  Although it will still be at least three to five years before they might be approved, I thought you might like to know about them.

Controll...